Pharma: The Year 2013 in Images
These are my favorite images that appeared in Pharma Marketing Blog posts made in 2013. It was a very interesting year, at least for...
Beware of Tweets Made by Hired Guns: Do You Have a Policy for That?
An ex-employee of Gedeon Richter, which is the largest biotechnology and pharmaceutical company based in Hungary, complained to the Prescription Medicines Code of Practice...
Should UnBranded Disease Awareness Ads Mention Treatment Risks?
False and misleading drug ads can harm consumers and the healthcare system. In order to limit the harm from false Rx drug advertising, FDA’s...
Being Too “Patient-Centric”: Spying on Patients on Social Media
I've written recently about the need for pharmaceutical companies to institute Customer Experience Centers of Excellence (here). This was in response to hearing about...
Does Pharma Really Need a 12-Step Program for Recovery of It’s Reputation? Or Will...
You've heard of the 12-Step Program of Alcohol Anonymous and you may have even heard of "The Twelve Steps of Pharma Social Marketers Anonymous"...
My Man in Milan
You have to be a big guy or gal in the pharma social media arena to wear the shirt off my back.
Davide Bottalico, MD,...
The Latest in Drug Safety: PhRMA Says Throw Unused Drugs in Household Trash
"For the second time," reports Pharmalot (here), "the pharmaceutical industry is challenging a local government over an ordinance that requires drugmakers to cover the...
Pharma Needs Customer Experience Centers of Excellence
Lately, I've been hearing a lot about "centers of excellence" at pharma companies as in "Digital Center of Excellence" and "Content Center of Excellence."...
Measuring Physician Interaction with Pharma Brands: Medikly’s Physician Value Index is a New Tool...
Venkat Gullapalli, MD and Mark Goldstone, Co-CEOs of Medikly, spoke on the Pharma marketing Talk show about PV Index™. This article summarizes that discussion.
Evaluating Rx & OTC DTC TV Ads: Few Are Outright False But Many May...
This article is a summary of a study that evaluated claims in consumer-targeted television drug advertising against pharmacological evidence in order to determine the frequency of false or misleading claims made in these ads.
















